XBiotech Inc.

News & Events

Press Releases

In The Media

1. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT

   PR Newswire FEB 4, 2025 4:20 PM EST
   INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - ...
   READ ARTICLE

2. XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm

   PR Newswire JAN 17, 2025 5:19 AM EST
   XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Fir...
   READ ARTICLE

3. Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating XBiotech for potential violations of securities laws

   GlobeNewswire JAN 14, 2025 4:37 PM EST
   PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION NEW YORK, Jan. 14, 2025 (GLOBE NEWS...
   READ ARTICLE

4. XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm

   Business Wire JAN 13, 2025 7:04 PM EST
   The Schall Law Firm , a national shareholder rights litigation firm, announces that it is inves...
   READ ARTICLE

5. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT

   PR Newswire JAN 8, 2025 12:00 PM EST
   SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc....
   READ ARTICLE

6. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT

   PR Newswire JAN 2, 2025 10:10 AM EST
   SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc....
   READ ARTICLE

7. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT

   PR Newswire DEC 27, 2024 4:20 PM EST
   SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc....
   READ ARTICLE

8. XBiotech Pauses Rheumatology program

   GlobeNewswire DEC 23, 2024 9:00 AM EST
   AUSTIN, Texas, Dec. 23, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today dat...
   READ ARTICLE

9. XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer

   GlobeNewswire JUN 18, 2024 11:35 AM EDT
   AUSTIN, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today dat...
   READ ARTICLE

10. Market Influences That Drive Equities Forward - New Research on Galena Biopharma, XBiotech, KEMET and Control4

    ACCESS Newswire DEC 24, 2015 8:05 AM EST
    NEW YORK, NY / ACCESSWIRE / December 24, 2015 / Moments ago, Trader's Choice released new re...
    READ ARTICLE